CHARLES SCHWAB INVESTMENT MANAGEMENT INC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$11,305,000
+36.1%
472,987
-16.9%
0.00%
+33.3%
Q4 2020$8,307,000
+5.4%
568,925
+2.5%
0.00%
-25.0%
Q3 2020$7,881,000
+9.4%
554,946
+13.3%
0.00%0.0%
Q2 2020$7,206,000
+430.6%
489,832
+48.6%
0.00%
+300.0%
Q1 2020$1,358,000
-13.1%
329,537
+1.5%
0.00%0.0%
Q4 2019$1,563,000
-18.5%
324,778
+2.6%
0.00%0.0%
Q3 2019$1,918,000
-9.3%
316,444
-2.8%
0.00%0.0%
Q2 2019$2,114,000
-3.6%
325,675
+5.4%
0.00%0.0%
Q1 2019$2,192,000
+52.6%
309,124
+4.7%
0.00%0.0%
Q4 2018$1,436,000
-34.7%
295,386
-1.3%
0.00%0.0%
Q3 2018$2,199,000
+25.4%
299,142
+8.8%
0.00%0.0%
Q2 2018$1,754,000
+38.4%
274,850
+18.1%
0.00%0.0%
Q1 2018$1,267,000
+34.4%
232,728
+3.0%
0.00%0.0%
Q4 2017$943,000
-54.9%
225,942
+4.2%
0.00%
-50.0%
Q3 2017$2,089,000
-22.0%
216,894
-4.2%
0.00%
-33.3%
Q2 2017$2,678,000
-11.5%
226,324
-4.1%
0.00%0.0%
Q1 2017$3,027,000
+38.0%
236,054
+31.7%
0.00%
+50.0%
Q4 2016$2,194,000
+18.3%
179,178
+14.0%
0.00%0.0%
Q3 2016$1,855,000
+42.9%
157,119
+5.3%
0.00%0.0%
Q2 2016$1,298,000
+69.0%
149,145
+2.4%
0.00%
+100.0%
Q1 2016$768,000
-30.4%
145,719
+2.6%
0.00%0.0%
Q4 2015$1,103,000
+2.6%
142,024
+4.0%
0.00%
-50.0%
Q3 2015$1,075,000
+13.2%
136,543
+30.3%
0.00%
+100.0%
Q2 2015$950,000
-44.5%
104,782
-20.5%
0.00%
-50.0%
Q1 2015$1,711,000
+0.6%
131,778
+5.5%
0.00%
-33.3%
Q4 2014$1,701,000
+101.8%
124,941
+33.1%
0.00%
+200.0%
Q3 2014$843,000
-32.2%
93,904
+2.2%
0.00%
-50.0%
Q2 2014$1,244,000
+51.3%
91,874
+11.2%
0.00%
+100.0%
Q1 2014$822,000
-23.0%
82,614
+3.0%
0.00%
-50.0%
Q4 2013$1,068,000
+12.8%
80,214
+3.7%
0.00%0.0%
Q3 2013$947,000
+53.5%
77,334
+32.1%
0.00%
+100.0%
Q2 2013$617,00058,5240.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders